Characterization of cytotoxicity induced by arsenic trioxide (a potent anti-APL drug) in rat cardiac myocytes
- 1 January 2009
- journal article
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 23 (1) , 61-68
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Survival Signaling by C-RAF: Mitochondrial Reactive Oxygen Species and Ca2+ Are Critical TargetsMolecular and Cellular Biology, 2008
- Health Effects of Early Life Exposure to ArsenicBasic & Clinical Pharmacology & Toxicology, 2008
- Safety and efficacy of arsenic trioxide for patients with advanced metastatic melanomaCancer, 2008
- Dithiothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular carcinoma cellsToxicology and Applied Pharmacology, 2008
- Transient Exposure to Hydrogen Peroxide Causes an Increase in Mitochondria-Derived Superoxide As a Result of Sustained Alteration in L-Type Ca 2+ Channel Function in the Absence of Apoptosis in Ventricular MyocytesCirculation Research, 2007
- Unusual Effects of a QT-Prolonging Drug, Arsenic Trioxide, on Cardiac Potassium CurrentsCirculation, 2004
- Prolongation of cardiac repolarization by arsenic trioxideBlood, 2002
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideNew England Journal of Medicine, 1998
- Hypoxia-reoxygenation induced increase in cellular Ca2+ in myocytes and perfused hearts: the role of mitochondriaJournal of Molecular and Cellular Cardiology, 1989
- Action of Iron, Cod-liver Oil, and Arsenic on the Globular Richness of the BloodThe American Journal of the Medical Sciences, 1878